These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 9796441
1. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy. Lin GC, Tsoukas ML, Lee MS, González S, Vibhagool C, Anderson RR, Kollias N. Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441 [Abstract] [Full Text] [Related]
2. Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Trauner KB, Gandour-Edwards R, Bamberg M, Shortkroff S, Sledge C, Hasan T. Photochem Photobiol; 1998 Jan; 67(1):133-9. PubMed ID: 9477771 [Abstract] [Full Text] [Related]
3. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer. Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Nango M, Oku N. Cancer; 2003 Apr 15; 97(8):2027-34. PubMed ID: 12673734 [Abstract] [Full Text] [Related]
4. Predictive dosimetry for threshold phototoxicity in photodynamic therapy on normal skin: red wavelengths produce more extensive damage than blue at equal threshold doses. Tsoukas MM, Lin GC, Lee MS, Anderson RR, Kollias N. J Invest Dermatol; 1997 Apr 15; 108(4):501-5. PubMed ID: 9077481 [Abstract] [Full Text] [Related]
5. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ. Cancer Res; 2003 Apr 15; 63(8):1806-13. PubMed ID: 12702566 [Abstract] [Full Text] [Related]
6. Polycation liposome enhances the endocytic uptake of photosensitizer into cells in the presence of serum. Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Ori H, Koishi T, Nango M, Oku N. Bioconjug Chem; 2003 Apr 15; 14(4):790-6. PubMed ID: 12862432 [Abstract] [Full Text] [Related]
7. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM. Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222 [Abstract] [Full Text] [Related]
8. Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome. Takeuchi Y, Ichikawa K, Yonezawa S, Kurohane K, Koishi T, Nango M, Namba Y, Oku N. J Control Release; 2004 Jun 18; 97(2):231-40. PubMed ID: 15196750 [Abstract] [Full Text] [Related]
9. Antiangiogenic photodynamic therapy with targeted liposomes. Oku N, Ishii T. Methods Enzymol; 2009 Jun 18; 465():313-30. PubMed ID: 19913174 [Abstract] [Full Text] [Related]
10. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma. Lilge L, Molpus K, Hasan T, Wilson BC. Photochem Photobiol; 1998 Sep 18; 68(3):281-8. PubMed ID: 9747583 [Abstract] [Full Text] [Related]
11. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Gomer CJ, Ferrario A. Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446 [Abstract] [Full Text] [Related]
12. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects. Chin W, Lau W, Cheng C, Olivo M. Int J Oncol; 2004 Sep 01; 25(3):623-9. PubMed ID: 15289863 [Abstract] [Full Text] [Related]
13. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model. Dube A, Sharma S, Gupta PK. Oral Oncol; 2006 Jan 01; 42(1):77-82. PubMed ID: 16140565 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat. Desroches MC, Bautista-Sanchez A, Lamotte C, Labeque B, Auchère D, Farinotti R, Maillard P, Grierson DS, Prognon P, Kasselouri A. J Photochem Photobiol B; 2006 Oct 02; 85(1):56-64. PubMed ID: 16765603 [Abstract] [Full Text] [Related]
15. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Ichikawa K, Takeuchi Y, Yonezawa S, Hikita T, Kurohane K, Namba Y, Oku N. Cancer Lett; 2004 Mar 08; 205(1):39-48. PubMed ID: 15036659 [Abstract] [Full Text] [Related]
16. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy. Aniola J, Selman SH, Lilge L, Keck R, Jankun J. Int J Mol Med; 2003 Mar 08; 11(3):287-91. PubMed ID: 12579328 [Abstract] [Full Text] [Related]
17. Experimental research photodynamic effects in perifocal, oedematous brain tissue. Goetz C, Hasan A, Stummer W, Heimann A, Kempski O. Acta Neurochir (Wien); 2002 Feb 08; 144(2):173-9; discussion 179. PubMed ID: 11862518 [Abstract] [Full Text] [Related]
18. Significance of dosimetry in photodynamic therapy of injured arteries: classification of biological responses. Adili F, Statius van Eps RG, LaMuraglia GM. Photochem Photobiol; 1999 Oct 08; 70(4):663-8. PubMed ID: 10546562 [Abstract] [Full Text] [Related]
19. Tissue distribution of a new photosensitizer ATX-S10Na(II) and effect of a diode laser (670 nm) in photodynamic therapy. Masumoto K, Yamada I, Tanaka H, Fujise Y, Hashimoto K. Lasers Med Sci; 2003 Oct 08; 18(3):134-8. PubMed ID: 14505196 [Abstract] [Full Text] [Related]
20. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice. Jiang FN, Richter AM, Jain AK, Levy JG, Smits C. Biotechnol Ther; 1993 Oct 08; 4(1-2):43-61. PubMed ID: 8374512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]